Evidence map›Paper›PMID 24492311›Full record

ArticleJPEN. Journal of parenteral and enteral nutrition2015

Association between prehospital vitamin D status and hospital-acquired Clostridium difficile infections.

Sadeq A Quraishi, Augusto A Litonjua, Takuhiro Moromizato, Fiona K Gibbons, Carlos A Camargo, Edward Giovannucci, Kenneth B Christopher

Open access · bronzeAbstract read
In one paragraph

Article in JPEN. Journal of parenteral and enteral nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Serum 25-hydroxyvitamin D levels andArchives of medical science : AMS · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Plasma 25-Hydroxyvitamin D and the Longitudinal Risk of Sepsis in the REGARDS Cohort.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sadeq A QuraishiDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston.
Augusto A LitonjuaChanning Division of Network Medicine and Pulmonary and Critical Care Division Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Takuhiro MoromizatoThe Nathan E. Hellman Memorial Laboratory, Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Fiona K GibbonsDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, Boston.
Carlos A CamargoDepartment of Emergency Medicine, Massachusetts General Hospital, Boston.
Edward GiovannucciDepartments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, Massachusetts.
Kenneth B ChristopherThe Nathan E. Hellman Memorial Laboratory, Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts kbchristopher@partners.org.
Brigham and Women's Hospital · USMassachusetts General Hospital · USHarvard University · US

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
Research Training for AnesthetistsT32GM007592 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI STUART A FORMAN · 1985 to 2026
$11.8M
Prospective Cohort Study of Severe Bronchiolitis and Risk of Recurrent WheezingU01AI087881 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CAMARGO, CARLOS ARTURO · 2011 to 2016
$6.2M
Effects of vitamin D and omega-3 fatty acids on infectious diseases and hCAP18R01AI093723 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI CAMARGO, CARLOS ARTURO · 2011 to 2015
$4.0M
Complement C1q Function in Allogeneic TransplantationK08AI060881 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI CHRISTOPHER, KENNETH BRUCE · 2005 to 2009
$621k
NCATS NIH HHS L30 TR001257NCRR NIH HHS UL1 RR025758NIAID NIH HHS K08 AI060881NIAID NIH HHS K08AI060881NIAID NIH HHS R01 AI093723NIAID NIH HHS U01 AI087881NIGMS NIH HHS 5T32GM007592-33NIGMS NIH HHS T32 GM007592
6 · The paper itself

Abstract

objectiveTo investigate whether preadmission 25-hydroxyvitamin D (25(OH)D) levels are associated with the risk of hospital-acquired Clostridium difficile infection (HACDI). MATERIALS AND

methodsOur retrospective cohort study focused on 568 adult patients from 2 Boston teaching hospitals between August 1993 and November 2006. All patients had 25(OH)D levels measured before hospitalization and were at risk for HACDI (defined as the presence of C difficile toxin A or B in stool samples obtained >48 hours after hospitalization). We performed multivariable regression analyses to test the association of prehospital 25(OH)D levels with HACDI while adjusting for clinically relevant covariates.

resultsIn these 568 patients, mean (SD) 25(OH)D level was 19 (12) ng/mL, and 11% of patients met criteria for incident HACDI. Following adjustment for age, sex, race (nonwhite vs white), patient type (medical vs surgical), and Deyo-Charlson index, patients with 25(OH)D levels <10 ng/mL had higher odds of HACDI (odds ratio [OR], 2.90; 95% confidence interval [CI], 1.01-8.34) compared with patients with 25(OH)D levels ≥30 ng/mL. When patients with HACDI were analyzed relative to a larger patient cohort without HACDI (n = 5047), those with 25(OH)D levels <10 ng/mL (OR, 4.96; 95% CI, 1.84-13.38) and 10-19.9 ng/mL (OR, 3.36; 95% CI, 1.28-8.85) had higher adjusted odds of HACDI compared with patients with 25(OH)D levels ≥30 ng/mL.

conclusionsIn our cohort of adult patients, vitamin D status before hospital admission was inversely associated with the risk of developing HACDI. These data support the need for randomized, controlled trials to test the role of vitamin D supplementation to prevent HACDI.

Indexed as

AgedAged, 80 and overClostridioides difficileClostridium InfectionsCross InfectionEndpoint DeterminationFemaleFollow-Up StudiesHospitalizationHumansLogistic ModelsMaleMiddle AgedRetrospective StudiesRisk FactorsVitamin DVitamin D25-hydroxyvitamin DClostridium difficilehospital-acquired infectionnosocomial infectionvitamin D

Identifiers

PMID24492311
PMCPMC4402285
OpenAlexW2059243922

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.